Skip to navigation menu Skip to content
Please click here to read our COVID-19 policies and resources before your visit or appointment. X
Jump to:  A   |   B   |   C   |   D   |   E   |   F   |   G   |   H   |   I   |   J   |   K   |   L   |   M   |   N   |   O   |   P   |   Q   |   R   |   S   |   T   |   U   |   V   |   W   |   X   |   Y

Drug Might Stop Heart Trouble Linked to Sickle Cell Anemia

Drug Might Stop Heart Trouble Linked to Sickle Cell Anemia

FRIDAY, Sept. 17, 2021 (HealthDay News) -- Treating sickle cell anemia with the drug hydroxyurea may also reverse related heart abnormalities, a new study suggests.

Heart issues are common among people with sickle cell disease. Among them are enlargement of the heart and an impaired ability to relax heart muscles, a condition called diastolic dysfunction that can lead to heart disease and heart failure and death. Long-term treatment with hydroxyurea, however, seems to improve and even reverse some of these abnormalities, researchers say.

"Early treatment with hydroxyurea should be offered to all children with sickle cell anemia starting at 9 months of age, regardless of disease severity," said lead researcher Dr. Arushi Dhar. She is a pediatric cardiologist at Cohen Children's Medical Center and the Zucker School of Medicine at Hofstra/Northwell in Hempstead, N.Y.

Close cardiac monitoring of children with sickle cell anemia, including asymptomatic patients, should start early, she said.

"At our institution, all children with sickle cell anemia are referred for baseline cardiac evaluation starting at 5 years of age," Dhar said.

Abnormalities, such as enlargement or thickening of one chamber of the heart and high blood pressure affecting the lungs, are common in kids with the disease.

Sickle cell anemia is the most common inherited red blood cell disorder in the United States. It affects an estimated 100,000 Americans, including one in every 365 Black people and one in 16,300 Hispanic Americans, according to the U.S. Centers for Disease Control and Prevention.

In those people, red blood cells, which are usually round, become crescent or sickle-shaped and then break apart, clump together and stick to the walls of blood vessels. This impairs blood flow, which can result in heart complications as well as severe pain, joint and organ damage, and stroke.

Hydroxyurea, one of the medications approved by the U.S. Food and Drug Administration to treat the disorder, prevents the formation of sickled cells. But exactly how it works is not understood. The drug can help patients have fewer pain crises and even live longer, according to the Sickle Cell Disease Association of America.

But this is the first study to show that hydroxyurea can also reverse heart damage linked to sickle cell, Dhar said.

For the study, her team collected data on 100 young people with sickle cell disease (aged 3 to 22). Half had enlargement or thickening in their heart's left ventricle. Some also had a type of high blood pressure (pulmonary hypertension) that affects the lungs and the right side of the heart.

Sixty participants were taking hydroxyurea. Twenty-five who had been on the drug for less than a year were significantly more likely to have left ventricle enlargement, the study found. Over the long term, cardiac outcomes were better among patients taking hydroxyurea, the researchers added.

The longer patients took the medication, the less likely they were to have an enlarged or thickened left ventricle. Among 34 patients who had an enlarged left ventricle when first seen, 18 had a normal one at their most recent visit, the researchers reported.

According to Dr. Lewis Hsu, chief medical officer of the Sickle Cell Disease Association of America, "These intriguing findings suggest hydroxyurea has benefits for another organ system in sickle cell disease."

He said the statistics suggest that hydroxyurea's anti-sickling impact is more important than its benefit of simply raising the oxygen-carrying capacity of blood.

But, he added, further study is called for.

"Studying cardiac remodeling retrospectively with no uniform starting point for hydroxyurea and a modest number of patients has many limitations," Hsu said. "I see this paper as a call for additional rigorous studies on this topic of preventing cardiac complications starting in the pediatric age."

The findings were published online Sept. 16 in the journal Blood Advances.

More information

To learn more about sickle cell anemia, visit the U.S. National Heart, Lung, and Blood Institute.

SOURCES: Arushi Dhar, MD, pediatric cardiologist, Cohen Children's Medical Center, Zucker School of Medicine at Hofstra/Northwell, Hempstead, N.Y.; Lewis Hsu, MD, pediatric hematologist and chief medical officer, Sickle Cell Disease Association of America, Hanover, Md.; Blood Advances, Sept. 16, 2021, online

Reviewed Date: --

Find a pediatrician
Childrens Orthopedics and Sports Medicine
Dr. James Bennett
Dr. J. Marc Cardelia
Dr. Peter Moskal
Dr. Cara Novick
Dr. Stephanie Pearce
Dr. Carl St. Remy
Sports Medicine
Dr. Joel Brenner
Dr. Aisha Joyce
Dr. Micah Lamb
Dr. David Smith
Dr. Tracy Alderson
Dr. Rose Cummings
Dr. Alexander Ellis
Dr. Robert Escalera II
Dr. Jonathan Fleenor
Dr. Lopa Hartke
Dr. John Reed
Dr. Elliot Tucker
Dr. Michael Vance
Children's Cardiac Surgery
Dr. Emily Downs
Dr. James Gangemi
Dr. Philip Smith
Hematology and Oncology
Dr. Wilson File
Dr. Eric Lowe
Dr. Melissa Mark
Dr. William Owen
Dr. Linda Pegram
Dr. Kevin Todd
Dr. Katherine Watson
Dr. Eric Werner
Dr. Sarah Chagnon
Dr. Wendy Edlund
Dr. Ralph Northam
Dr. Crystal Proud
Dr. Svinder Toor
Dr. Ryan Williams
Health Tips
Helping Kids Get Over their Fears
When Can a Child Wear Contact Lenses
Heart Health Quiz
Heart Quiz for Women Only
Sickle Cell Disease Quiz
Teen Health Quiz
Diseases & Conditions
Adolescent (13 to 18 Years)
Amenorrhea in Teens
Anatomy of a Child's Brain
Anatomy of the Endocrine System in Children
Anomalous Coronary Artery in Children
Anxiety Disorders in Children
Asthma in Children Index
Autosomal Recessive: Cystic Fibrosis, Sickle Cell Anemia, Tay Sachs Disease
Becker Muscular Dystrophy (BMD) in Children
Bone Marrow Transplant for Children
Brain Tumors in Children
Breast Conditions in Young Women
Chemotherapy for Children: Side Effects
Ewing Sarcoma in Children
Female Growth and Development
Gynecological and Menstrual Conditions
Heart Failure in Children
Hepatitis B Virus (HBV) in Children
High Blood Pressure in Children and Teens
High-Risk Newborn Blood Disorders
Home Page - Adolescent Medicine
Home Page - Cardiovascular Disorders
Inflammatory and Infectious Musculoskeletal Disorders
Inflammatory and Infectious Neurological Disorders
Inguinal Hernia in Children
Insect Bites and Children
Kidney Transplantation in Children
Major Depression in Teens
Meningitis in Children
Menstrual Cramps (Dysmenorrhea) in Teens
Menstrual Disorders
Mood Disorders in Children and Adolescents
Myasthenia Gravis (MG) in Children
Oral Health
Osteosarcoma (Osteogenic Sarcoma) in Children
Pap Test for Adolescents
Pediatric Blood Disorders
Posttraumatic Stress Disorder (PTSD) in Children
Pregnancy and Medical Conditions
Pregnancy and Pre-existing Heart Disease
Preparing the School-Aged Child for Surgery
Schizophrenia in Children
School-Aged Child Nutrition
Sickle Cell Disease and Pregnancy
Sickle Cell Disease in Children
Sports Safety for Children
Superficial Injuries of the Face and Head- Overview
Teens and Diabetes Mellitus
Television and Children
The Growing Child- Teenager (13 to 18 Years)
The Growing Child: 2-Year-Olds
The Heart
The Kidneys
Your Child's Asthma
Your Child's Asthma: Flare-ups

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.